Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Multiples show growing appetite for acquisitions

Business Removal of 100-hour exemption has fuelled interest in growing networks, brokers and lawyers say

Multiples are displaying a renewed interest in buying pharmacies as overall confidence in the market grows, brokerage groups have revealed.


There was a "cautious appetite" among the multiples to build up their networks, brokers Christie+Co and Hutchings Consultants told C+D.


They put the trend largely down to the removal of the 100-hour exemption in September 2012, which they said had brought greater stability to the pharmacy market.


Broker Hutchings Consultants said goodwill values had  risen by 10 to 20 per cent last year, once the threat of 100-hour pharmacies had disappeared

More on the 100-hour exemption

100 hours continues to fuel pharmacy openings

Pharmacists fear online competition

Supermarket pharmacies could undermine sector's accessibility, warns Andy Burnham

Christie+Co said this marked the end of a quiet period for the multiples, which had tended to restrict themselves to "defensive" applications over the past three years.


Although independents were still making the "vast majority" of acquisitions, Christie+Co head of pharmacy Tony Evans said multiples were now keen to invest in their businesses. "I think it will be interesting to see how the [multiples] coming into the market affects prices," Mr Evans told C+D.


Fellow broker Hutchings Consultants said goodwill values had already risen by 10 to 20 per cent last year, once the threat of 100-hour pharmacies had disappeared.


"This was fuelled by the large number of buyers who were out in force, creating a very strong sellers' market," explained Anne Hutchings, managing director of Hutchings Consultants. "Among the buyers, we have seen a renewed interest from some of the multiples and many large and medium-sized groups, which are also very keen to buy at the moment."


Tim Jenkins, a partner at law firm Charles Russell who specialises in healthcare acquisitions, said confidence was now returning to the pharmacy market "across the board". "In our view, it is due to a combination of the removal of the threat of 100-hour competition, increased bank lending and general improvement in the economic outlook," he said.


But the Independent Pharmacy Federation said the trend had largely gone unnoticed at a local level. Chief executive Claire Ward said she was unaware of contractors reporting any "major activity" from the multiples.


Lambeth, Southwark and Lewisham LPC Jignesh Patel also reported little activity in his area, but pointed out that London was a particularly difficult area for pharmacy businesses. "The pressure is on [pharmacies] in inner London areas because of the property boom, which has led to higher rental," he told C+D.



Have you noticed greater interest from the multiples in buying pharmacies?

Comment below or email us at [email protected] You can also find C+D on Twitter, LinkedIn and Facebook

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD016759

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel